tradingkey.logo

SNWV

SNWV
查看詳細走勢圖
31.020USD
-1.230-3.81%
收盤 12/22, 16:00美東報價延遲15分鐘
266.03M總市值
虧損本益比TTM

SNWV

31.020
-1.230-3.81%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-3.81%

5天

-1.96%

1月

-6.62%

6月

-7.90%

今年開始到現在

0.00%

1年

0.00%

查看詳細走勢圖

TradingKey SNWV股票評分

單位: USD 更新時間: 2025-12-22

操作建議

SANUWAVE Health Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名98/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價54.00。中期看,股價處於平穩狀態。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

SNWV評分

相關信息

行業排名
98 / 208
全市場排名
234 / 4578
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
買入
評級
54.000
目標均價
+80.72%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

SNWV亮點

亮點風險
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
業績高增長
公司營業收入穩步增長,連續3年增長94.92%
業績增長期
公司處於發展階段,最新年度總收入32.63M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入32.63M美元
估值低估
公司最新PE估值-60.01,處於3年歷史低位
機構加倉
最新機構持股4.71M股,環比增加15.21%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉440.28K股

SNWV新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

SNWV簡介

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
公司代碼SNWV
公司SANUWAVE Health Inc
CEOFrank (Morgan C)
網址https://sanuwave.com/

常見問題

SNWV(SNWV)的當前股價是多少?

SNWV(SNWV)的當前股價是 31.020。

SNWV 的股票代碼是什麼?

SNWV的股票代碼是SNWV。

SNWV股票的52週最高點是多少?

SNWV股票的52週最高點是46.585。

SNWV股票的52週最低點是多少?

SNWV股票的52週最低點是20.500。

SNWV的市值是多少?

SNWV的市值是266.03M。

SNWV的淨利潤是多少?

SNWV的淨利潤為-31.37M。

現在SNWV(SNWV)的股票是買入、持有還是賣出?

根據分析師評級,SNWV(SNWV)的總體評級為買入,目標價格為54.000。

SNWV(SNWV)股票的每股收益(EPS TTM)是多少

SNWV(SNWV)股票的每股收益(EPS TTM)是-0.517。
KeyAI